Correlation Between Atreca and ADC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Atreca and ADC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atreca and ADC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atreca Inc and ADC Therapeutics SA, you can compare the effects of market volatilities on Atreca and ADC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atreca with a short position of ADC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atreca and ADC Therapeutics.
Diversification Opportunities for Atreca and ADC Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Atreca and ADC is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Atreca Inc and ADC Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADC Therapeutics and Atreca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atreca Inc are associated (or correlated) with ADC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADC Therapeutics has no effect on the direction of Atreca i.e., Atreca and ADC Therapeutics go up and down completely randomly.
Pair Corralation between Atreca and ADC Therapeutics
If you would invest 104.00 in Atreca Inc on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Atreca Inc or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Atreca Inc vs. ADC Therapeutics SA
Performance |
Timeline |
Atreca Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ADC Therapeutics |
Atreca and ADC Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Atreca and ADC Therapeutics
The main advantage of trading using opposite Atreca and ADC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atreca position performs unexpectedly, ADC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADC Therapeutics will offset losses from the drop in ADC Therapeutics' long position.Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
ADC Therapeutics vs. Passage Bio | ADC Therapeutics vs. Black Diamond Therapeutics | ADC Therapeutics vs. Alector | ADC Therapeutics vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |